Cipla Company Description

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry.

The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Cipla Limited

Country	India
Founded	1935
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	31,369
CEO	Achin Gupta

Contact Details

Address: Cipla House Mumbai, 400013 India
Phone	91 22 2482 6000
Website	cipla.com

Stock Details

Ticker Symbol	CIPLA
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE059A01026
SIC Code	2834

Key Executives

Name	Position
Achin Gupta	MD, Global Chief Executive Officer and Director
Sushrut Kulkarni	President and Global Chief Integrated Product Development
Ashish Adukia	Global Chief Financial Officer
Dinesh Ramniranjan Jain	Senior Vice President and Head of Corporate Finance
Sneha Hiranandani B Com	Global Chief Information Officer
Diksha Maheshwari	Head of Investor Relations
Rajendra Kumar Chopra	Compliance Officer and Company Secretary
Meera Vanjari	Global Chief General Counsel
Heena Kanal	Chief of Corporate Communication
Arun Kakatkar	Global Chief People Officer